BioAim Scientific (Kanada)
The Bioaim Human TRAIL ELISA kit is a solid phase sandwich ELISA (enzyme-linked immunosorbent assay) for the quantitative measurement of TRAIL in Human serum, plasma and cell culture media. An antibody specific for Human TRAIL was coated on a 96-well plate. Standards and samples are added to the wells and any TRAIL present binds to the immobilized antibody. The wells are washed and biotinylated anti-Human TRAIL antibody is added. After washing away unbound biotinylated antibody, HRP-conjugated streptavidin is added to the wells. The wells are again washed and TMB substrate solution is added, which produces a blue color in direct proportion to the amount of TRAIL present in the initial sample. The Stop Solution changes the color from blue to yellow, and the microwell absorbances are read at 450 nm.Research Area Apoptosis;
tumor necrosis factor superfamily member 10(TRAIL) Background: TNF-related apoptosis-inducing ligand (TRAIL), also known as Apo-2 ligand and TNFSF10, is a type II transmembrane protein with a carboxy-terminal extracellular domain that exhibits homology to other TNF superfamily members. The N-terminal cytoplasmic domain is not conserved across family members, however, the C-terminal extracellular domain is conserved and can be proteolytically cleaved from the cell surface. TRAIL forms a homotrimer that binds three receptor molecules. TRAIL binds to the death receptors DR4 (TRAIL-RI) and DR5 (TRAIL-RII). The process of apoptosis is caspase-8-dependent. Caspase-8 activates downstream effector caspases including procaspase-3, -6, and -7, leading to activation of specific kinases.
APO2L, Apo-2L, CD253, TL2, TNLG6A, TRAIL
Serum, plasma, Cell culture supernatant
|Antigen Name||tumor necrosis factor superfamily member 10|
|Detection Range||40.9-10000 pg/ml|
|Alias||APO2L, Apo-2L, CD253, TL2, TNLG6A, TRAIL|